Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
GLP-1 agonism: Reduces appetite, slows gastric emptying, promotes satiety GIP agonism: Enhances insulin secretion, may reduce GLP-1-related nausea Glucagon agonism: Increases hepatic glucose output control, drives thermogenesis and energy expenditure Phase 2 clinical trial data published in 2023 showed subjects lost an average of 24.2% of body weight over 48 weeks making it arguably the most potent weight-loss compound currently known
Our focus on consistency, clear documentation, and responsible sourcing minimizes experimental variability and supports robust metabolic study design
, 497 , 1117-1122, doi: Tili, E., Michaille, J
For extra cooling and de-puffing, chill in the fridge before use
It is a genuinely innovative medication
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
In fact, during Hersheys Q1 2026 earnings call, the companys CEO reported that sales of Ice Breakers mints and gum increased more than 8%, attributing the rise in part to people taking GLP1 medications and trying to manage bad breath
